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Abstract
Background: Cadmium (Cd) is a nonessential heavy metal, causing oxidative
damage to various tissues and associated with hypertension. Tetrahydrocurcumin
(THU), a major metabolite of curcumin, has been demonstrated to be an
antioxidant, anti-diabetic, anti-hypertensive and anti-inflammatory agent. In this
study, we investigated the protective effect of THU against Cd-induced
hypertension, raised arterial stiffness and vascular remodeling in mice.
Methods: Male ICR mice received CdCl2 (100 mg/l) via drinking water for 8 weeks.
THU was administered intragastrically at dose of 50 or 100 mg/kg/day concurrently
with Cd treatment.
Results: Administration of CdCl2 significantly increased arterial blood pressure,
blunted vascular responses to vasoactive agents, increased aortic stiffness, and
induced hypertrophic aortic wall remodeling by increasing number of smooth
muscle cells and collagen deposition, decreasing elastin, and increasing matrix
metalloproteinase (MMP)-2 and MMP-9 levels in the aortic medial wall.
Supplementation with THU significantly decreased blood pressure, improved
vascular responsiveness, and reversed the structural and mechanical alterations of
the aortas, including collagen and elastin deposition. The reduction on the adverse
response of Cd treatment was associated with upregulated eNOS and
downregulated iNOS protein expressions, increased nitrate/nitrite level, alleviated
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oxidative stress and enhanced antioxidant glutathione. Moreover, THU also
reduced the accumulation of Cd in the blood and tissues.
Conclusions: Our results suggest that THU ameliorates cadmium-induced
hypertension, vascular dysfunction, and arterial stiffness in mice through enhancing
NO bioavailability, attenuating oxidative stress, improving vascular remodeling and
decreasing Cd accumulation in other tissues. THU has a beneficial effect in
moderating the vascular alterations associated with Cd exposure.
Introduction
Cd, in its ionic form (Cd2+), is a highly toxic metal that is widely distributed in the
environment. The risk of human exposure to Cd is steadily increasing through a
variety of routes, including industrial contamination, food sources and tobacco
smoke [1]. Exposure to Cd can result in a variety of adverse effects in humans and
animals. It induces oxidative stress, damaging organs such as kidneys, liver, bone,
lungs as well as the endocrine, immune, reproductive and cardiovascular systems
[2–4]. Interestingly, it has been demonstrated that the vascular system is a critical
target of Cd toxicity, leading to an increased risk of cardiovascular disease (CVD)
such as hypertension, atherosclerosis and diabetes [5–7]. Many epidemiological
studies have suggested a positive association between blood Cd2+ level and blood
pressure in the general population [8–11]. Many animal studies have shown that
chronic exposure to Cd can lead to elevated blood pressure [12–15]. However, the
exact biological mechanisms that link Cd exposure and hypertension remain
unclear. A marked increase in oxidative stress during Cd exposure affects the
vascular cells at a variety of molecular levels, thereby leading to vascular damage
and dysfunction [16–18]. Furthermore, oxidative stress in the vasculature also
reduces the availability of the vasodilator nitric oxide (NO), causes vascular tissue
injury and inflammation, as well as promoting lipid, protein and DNA damage
[19]. Previous studies suggest that reactive oxygen species (ROS) and reactive
nitrogen species (RNS) are important intracellular signaling molecules that
regulate vascular function by modulating vascular cell contraction/dilation,
growth/apoptosis, migration, and extracellular matrix protein turnover. All of
these factors contribute to vascular remodeling and stiffening [20]. Therefore,
reducing the presence of ROS, increasing NO bioavailability and augmenting the
regression of remodeling and stiffening are important therapeutic strategies
against hypertension.
There are several studies describing the use of antioxidant and metal chelating
agents for the treatment of metal poisoning. The most important source of
antioxidants is provided by nutrition. Apart from their free radical scavenging
activities, nutritional antioxidants are known to regulate the expression of number
of genes and signal regulatory pathways and thereby to prevent cell death [21].
THU is an antioxidative substance which is derived from curcumin by
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hydrogenation. Curcumin is a phenolic compound extracted from the rhizome of
turmeric (Curcuma longa Linn) of the Zingiberaceae family. THU possesses strong
antioxidant and free radical scavenging properties [22–23] and contains the same
phenolic and b-diketo moieties as curcumin. Recently, much attention has been
focused on THU, as it appears to exert greater antioxidant activity than curcumin
[24–27]. THU effectively protects against oxidative stress, endothelial dysfunction,
diabetes and hypertension [28–30]. It has been reported that THU enhances
antioxidant enzyme activities, including superoxide dismutase, catalase and
glutathione peroxidase, whereas it decreases thiobarbituric acid reactive substance,
hydroperoxide and protein carbonyl formation [24, 26, 28]. Moreover, THU
reduced the infarct size in an ischemic–reperfusion model of myocardial
infarction [31] and these effects were associated with reduced lipid peroxidation
and improved antioxidant status. Therefore, THU may be beneficial for
cardiovascular protection, especially against hypertension, by decreasing oxidative
stress in the vascular system. Although THU exerts important effects on reduction
of blood pressure and arterial stiffening in L-NAME-induced hypertension [30],
these valuable effects have not been explored in a model of heavy metal toxicity.
In the present study, we hypothesized that THU could alleviate hypertension,
vascular dysfunction and vascular remodeling in mice exposed to Cd. Since ROS
can induce endothelial nitric oxide synthase (eNOS) uncoupling and activate
MMPs [19, 32], THU as a strong antioxidant may improve NO bioavailability and
inhibit MMP activation. Therefore, we have also examined whether THU would
attenuate vascular oxidative stress in mice during Cd exposure.
Materials and Methods
Chemicals and Drugs
THU (purity.99% w/w by HPLC chromatogram) was synthesized and provided
by the Research and Development Institute, The Government Pharmaceutical
Organization, Bangkok, Thailand. Phenylephrine (Phe), thiobarbituric acid
(TBA), 5,5 dithio-bis-2-nitrobenzoic acid (DTNB), ethylenediamine tetraacetic
acid (EDTA), sodium dodecyl sulfate (SDS), glutathione (GSH), butylated
hydroxytoluene (BHT), sulfanilamide, dinitrophenylephrinenylhydrazine
(DNPH), N-1-nepthylethylenediamine dihydrochloride (NED), 1,1,3,3-tetra-
ethoxypropane, bromophenol blue, 2-mercaptoetanol, lucigenin and guanidine
were purchased from Sigma-Aldrich Pte. Ltd. (Singapore). Nitrate reductase,
nicotinamide adenine dinucleotide phosphate (NADPH) and glucose-6-phos-
phate dehydrogenase were obtained from Roche Applied Sciences (Mannheim,
Germany). Acetylcholine chloride (ACh), sodium nitroprusside (SNP), trichlor-
oacetic acid (TCA), metaphosphoric acid (MPA), 1-methyl-2 vinyl-pyridinum
trifate (M2VP), lucigenin, Tween and skimmed milk were obtained from Fluka
Chemika Co. Ltd (Buch, Switzerland). Mouse monoclonal anti-eNOS was
obtained from BD Biosciences (CA, USA). Anti-mouse IgG antibody, a rabbit
polyclonal anti-inducible nitric oxide symthase (iNOS) antibody and anti-rabbit
Tetrahydrocurcumin Ameliorates Cadmium-Induced Vascular Alterations
PLOS ONE | DOI:10.1371/journal.pone.0114908 December 11, 2014 3 / 21
IgG antibody were purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). All other chemicals used were of analytical grade quality.
Animals and Experimental Protocols
Adult male ICR mice weighing 25–30 g were obtained from the National
Laboratory Animal Center, Mahidol University, Salaya (Nakornpathom,
Thailand). The animals were housed at The Northeast Laboratory Animal Center
(Khon Kaen University, Thailand) and maintained on a 12-h dark/light cycle at
room temperature (25¡2 C˚) with free access to standard rat chow (Chareon
Pokapan Co. Ltd., Thailand). This study was carried out in strict accordance with
the recommendations in the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health. The protocol was approved by the Committee
on the Ethics of Animal Experiments of the Khon Kaen University (Permit
Number: AEKKU42/2554). All surgery was performed under the standard
anesthetic drugs, and all efforts were made to minimize suffering.
After 1 week of acclimatization, mice were randomly divided into six
experimental groups (N58–10/group). Group I, normal controls, received
deionized water (DI) as drinking water and were treated with polyethylene glycol
(PG), the THU vehicle, administered intragastrically at 1.5 ml/kg/day. Groups II
and III, THU-controls, received DI and were treated with THU at doses of 50 and
100 mg/kg/day respectively, administered intragastrically 5 days/week for 8 weeks.
Groups IV, V, and VI received DI containing CdCl2 (100 mg/l) in their drinking
water and administered THU at doses of 50 or 100 mg/kg/day (dissolved in PG),
again for 5 days/week for 8 weeks. THU was kindly provided by the Government
Pharmaceutical Organization (Bangkok, Thailand). The doses of Cd and THU
were chosen on the basis of previous studies [30, 33].
Measurement of Blood pressure, Heart rate and Assessment of
Vascular Reactivity
At the end of the treatment period, the animals were anesthetized with an
intraperitoneal injection of ketamine (100 mg/kg) and xylazine (2.5 mg/kg).
Blood pressure and vascular reactivity were determined as previously described
[14]. A tracheotomy was performed for spontaneous breathing. The animal’s
body temperature was kept constant at 37¡2 C˚ by a heating pad. The right
carotid artery was exposed and cannulated with polyethylene tubing connected to
a pressure transducer for monitoring arterial blood pressure and heart rate using
the Acqknowledge data acquisition system (Biopac System Inc., CA, USA). The
left jugular vein was exposed and cannulated with polyethylene tubing for
infusion of vasoactive agents. After obtaining baseline measurements, ACh
(10 nmol/kg), an endothelium-dependent vasodilator, SNP (10 nmol/kg), an
endothelium-independent vasodilator, and Phe (0.03 mmol/kg), an alpha
sympathomimetic agent, were randomly infused intravenously, while blood
pressure was continuously monitored. Following the drug infusion, blood
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pressure was allowed to return to the baseline level and stabilize for at least
5 minutes. Changes in blood pressure were expressed as percentages of control
values obtained immediately before administration of the test substance
(baseline). At the end of the experiment, the animals were sacrificed by anesthetic
overdose, blood samples were collected from the abdominal aorta for assays of the
antioxidant GSH and oxidative stress makers (see below). Thereafter, the aorta
was rapidly excised and the amount of superoxide (O2
N-) production in each
specimen was measured. In a separate set of experiments, blood and tissues of
each animal were collected for assessments Cd content, aortic elasticity and
vascular remodeling.
Assays of Nitrate/nitrite, Oxidative Stress Markers and the
Antioxidant Glutathione
Accumulation of nitrate and nitrite, the oxidative products of NO, was measured
in urine samples using a previously described method [14]. The production of
O2
N- in mouse aorta was determined by the lucigenin-enhanced chemilumines-
cence method as previously described [14]. The malondialdehyde (MDA), a lipid
peroxidation marker, was assessed in the plasma, heart, kidney and liver using the
TBA assay [33]. The protein carbonyl, a protein oxidation marker, in the plasma
and tissues, was assessed by the determination of carbonyl groups based on the
reaction with DNPH as previously described [33]. MDA and protein carbonyls
concentrations in the tissues were normalized against the tissue protein
concentration, which was determined by the Bradford dye binding method [34].
GSH in the blood was determined spectrophotometrically, again following a
previously described method [35].
Western Blot Analysis
NO, normally synthesized by eNOS plays a role in the regulation of vascular
function. However, under conditions of stress, such as inflammation, several
oxidative stressors can induce the expression of iNOS, which thereby induces NO
production [36]. Therefore, we determined both eNOS and iNOS protein
expression in the aortas of all studied animals, by Western blotting as previously
described [37]. The expressions of eNOS and iNOS were normalized to b-actin
expression from the same sample. The data were expressed as a percentage of
normal controls.
Assessment of Aortic Elasticity
In a separate set of experiments, after the animals were killed by overdose of the
anesthetic drug, the quasi static aortic elasticity (n56-8/group) was assessed. In
brief, the thoracic aorta was cannulated in situ with polyethylene catheters, one
distal to the arch and the other just below the diaphragm. The aorta was perfused
with barium sulfate through the thoracic cannula and inflated at varying pressures
ranging from 0-200 mmHg at 20 mmHg intervals. Each pressure was allowed to
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stabilize for 30 seconds and an image of the aorta filled with the barium sulphate,
which helped localize small leaks and improved the contrast of the aorta against
the surrounding tissue, was taken with a digital camera fitted with macro lens
(Canon EOS 40D, Canon Marketing (Thailand) Co., Ltd., Bangkok, Thailand)
The external diameter of the aorta was derived from these images with the aid of
Image-Pro Plus software (Media Cybernetics, Silver Spring, MD, USA). Firstly,
the area of each segment of the aorta measured at each perfusion pressure was
determined by tracing the edges of the vessel with the computer mouse and
determining the ferret length of the outlined area. Knowing the length of the
outlined image, De of the aorta at various pressures was calculated by dividing the
area by the length. For each aortic segment the inflation was performed twice and
the two diameter readings at each pressure were averaged.
After completing the inflation experiment and flushing out the barium sulfate,
the in-situ length of the thoracic aorta was measured, after which it was excised
from the animal and weighed. Knowing the volume of the vessel from its weight
and its length in situ, the cross-sectional area (CSA) can be calculated from; CSA
5 Mass/Length x r, where density of the tissue (r) is 1.06 mg/mm3. The wall
thickness (h) of the vessel was calculated as the difference between the by external
radius (Re) and internal radius (Ri). Re was taken as De/2. and Ri was derived from
the expression: Ri5 [(De/2)
2 – (CSA/p)]K. Midwall radius (Rm) was calculated
as; Rm5Re -(h/2). The relative wall thickness was used to normalize h with Rm at
each pressure. Langewouter’s equation [38] was used to fit the data points to
obtain the pressure-diameter relationship in analytical form from which the
gradient at any point could be derived. The functional stiffness (Peterson’s elastic
modulus) (Ep) and material stiffness (the circumferential incremental elastic
modulus) (Einc) were calculated from the relative change in blood vessel radius in
response to a known change in pressure following the equations; Ep5 (DPRm
2)/
(DRmh) and Einc 50.75 (DPRm
2)/(DRmh), where DP is the pressure increment
and DR is a change in radius due to DP. Relative radius (DRm) or circumferential
extension ratio was used to normalize Rm with Rm at the pressure of 0 mmHg.
Morphometric Analysis and Composition of the Vascular Wall
The middle portion of the descending thoracic aortas were cleaned, fixed in
4%phosphate-buffered paraformaldehyde, pH 7.4, and embedded in paraffin
blocks. Slices, 4 mm thick were stained with hematoxylin and eosin (H&E),
Picrosirius red, and Miller’s elastic stain to determine the number of smooth
muscle cells (SMCs), the area fractions of collagen and elastin in the aortic media,
respectively [39]. The number of SMCs was obtained by counting their nuclei in
the sections stained with H&E. The area fraction of collagen or elastin in the aortic
media was assessed by counting threshold pixels stained with Picrosirius red or
Miller’s elastic staining and dividing by the total number of medial pixels. The
stained sections were examined with light microscopy and the image was captured
at 6400. The composition of the aortic wall was evaluated using KS400 image
analysis system (Carl Zeiss Microscopy, Imaging Associates Ltd., Bicester, UK).
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Immunohistochemistry to Detect Vascular MMP-2 and MMP-9
In order to assess MMP-2 and MMP-9 localization in the thoracic aorta, the de-
waxed aortic sections were analyzed using specific antibodies (ab37150; Abcam
and ab19016; Millipore, respectively), and an immunohistochemical technique
using the R.T.U. Vectastain ABC kit (Vector Laboratories, Inc., CA, USA) as
previously described [40]. The experimental conditions were optimized to
generate a strong and specific signal for the antigen of interest. The measurements
were performed in a single batch and the specimens were stained together with a
positive control at the same time. The stained sections was examined with light
microscopy and the images were captured at 6400. The amount of MMP2 or
MMP-9 in the aortic wall was measured, as were collagen and elastin, by counting
the thresholded pixels stained with antibodies to MMP-2 or MMP-9 using the
Image-Pro Plus Program (Media Cybernetics, MD, USA). All measurements were
made by one observer and preliminary observations of intra-observer repeatability
showed a coefficient of variation of less than 5% for all estimations of thresholded
area.
Cd Assay
Cd content in the blood and tissues, including the aorta, heart, liver and kidney
was determined as previously described [35] using inductively coupled plasma
mass spectrometry (ICP-MS) (Agilent 7500 ICP-MS model, Santa Clara, CA,
USA) according to the manufacturer’s recommendation. The Cd contents were
expressed in mg/l and mg/g of tissue wet weight.
Statistical Analysis
Results are expressed as mean ¡ SEM., and n refers to the number of animals
used. Statistical evaluation was performed by one-way analysis of variance
(ANOVA) followed by Newman–Keuls post-hoc test to show specific group
differences. Statistical significance was determined at a level of P,0.05.
Results
THU Attenuates Cd-Induced Hypertension and Vascular
Dysfunction
Arterial blood pressure (BP) and heart rate (HR) of all experimental groups are
shown in Table 1. Systolic blood pressure, diastolic blood pressure and mean
arterial pressure were increased in mice exposed to Cd (P,0.05).
Supplementation with THU significantly decreased blood pressure when
compared with mice receiving Cd alone in a dose dependent manner (P,0.05).
There was no change in HR among all groups (Table 1).
Vascular hyporesponsiveness to Phe, ACh and SNP was found in mice exposed
to Cd (P,0.05; Fig. 1), indicating that vasodilating and vasoconstricting
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properties are impaired during Cd exposure. Interestingly, impairment of vascular
responsiveness was largely prevented by THU as shown in Fig. 1. THU, especially
at 100 mg/kg significantly increased vascular responsiveness to Phe (44% vs.
28%), ACh (44% vs. 27%), and SNP (34% vs. 25%) when compared to the
behaviour of mice receiving Cd alone (P,0.05; Fig. 1).
Table 1. Effect of THU on arterial blood pressure and heart rate in all experimental groups.
Variables Untreated control Control + THU (mg/kg) Cd control Cd + THU (mg/kg)
50 100 50 100
Systolic pressure (mmHg) 117¡3 122¡2 123¡2 160¡2 * 139¡2 *{ 129¡ 2*{
Diastolic pressure (mmHg) 81¡3 76¡2 82¡4 119¡2 * 101¡2 *{ 80¡2{
MAP (mmHg) 96¡3 97¡1 101¡2 142¡3 * 119¡2 *{ 100¡1{
Heart rate (beats/min) 336¡11 339¡7 336¡13 336¡8 341¡14 333¡9
Data are expressed as mean¡ SEM., n5 8–10/group. MAP, mean arterial pressure. *P,0.05 compared with normal control group, {P,0.05 compared with
Cd control group.
doi:10.1371/journal.pone.0114908.t001
Fig. 1. Effect of THU on alteration of blood pressure in response to vasoactive agents in all
experimental groups. Change in mean arterial pressure (MAP) was calculated as a percentage of baseline
MAP after challenge with each vasoactive agent. Results are expressed as mean ¡ SEM., n58–10/group.
*P,0.05 compared with untreated control group; {P,0.05 compared with Cd control group.
doi:10.1371/journal.pone.0114908.g001
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Fig. 2. Effect of THU on eNOS (A) and iNOS (B) protein expressions in the aortas of mice in all
experimental groups. Plots show the densitometric intensities of eNOS and iNOS protein expressions for
each condition, normalized against b-actin expression and presented as percentage of untreated control
values. Results are expressed as mean ¡ SEM., n55–6/group. *P,0.001 compared with normal control
group; {P,0.001 compared with Cd control group.
doi:10.1371/journal.pone.0114908.g002
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THU Prevents Cd-Induced Alterations in NO
Cd profoundly suppressed eNOS but enhanced iNOS expression in mice aortas
(P,0.001; Fig. 2A, B), revealing the alteration of the eNOS/iNOS pathway in Cd
exposure. Moreover, a marked increase in urinary nitrate/nitrite was found in Cd
exposed mice (P,0.001; Table 2), and this was associated with the increase in
iNOS protein. Interestingly, it is apparent that THU upregulated eNOS and
downregulated iNOS protein expressions in the aortic tissue and decreased
urinary nitrate/nitrite level in Cd exposed mice. THU at both doses did not
modify eNOS and iNOS expressions in the aortas of non Cd treated controls.
THU Ameliorates Cd-Induced Arterial Stiffness
The elastic properties of animals administered vehicle only and those given THU
dissolved in the vehicle did not differ. Therefore, only the data of the vehicle-alone
controls and the Cd- treated groups with or without THU co-administration are
displayed in Fig. 3. The aortic relative wall thickness of mice exposed to Cd was
significantly greater than normal controls over the entire range of distending
pressures (P,0.001; Fig. 3A), indicating that Cd induced vascular structural
changes. The circumferential extension ratio of the thoracic aorta of Cd-treated
mice was diminished at pressures ranging from 160–200 mmHg although not at
physiological pressures (P,0.05; Fig. 3B), suggesting a reduction in aortic
compliance after Cd exposure. Supplementation with THU ameliorated the
vascular structural changes and increased aortic compliance towards control
values, as shown in Fig. 3A, B.
Fig. 3C and D show the relationships of Ep with pressure and Einc with
circumferential extension ratio, respectively. Cd significantly shifted the curves to
the left which implies that Ep (Fig. 3C) and Einc (Fig. 3D) were increased after Cd
exposure indicating that Cd causes increases in both functional and structural
aortic stiffness. THU at both doses significantly reduced the aortic stiffness in Cd-
treated mice (P,0.001; Fig. 3C, D), although at physiological pressures the
reduction was not sufficient to reach control values.
THU Improves Cd-Induced Vascular Remodeling
When compared to the untreated controls, Cd-induced hypertension was
associated with arterial wall hypertrophy, a significant increase in the number of
VSMCs and increased collagen content in the aortic wall (P,0.05; Fig. 4A, B).
In addition, aortic elastin content was decreased in Cd-treated mice (P,0.05;
Fig. 4C), a result in keeping with the Cd-associated increase in arterial stiffness.
THU treatment, especially at high dose, inhibited the vascular structural
alterations induced by Cd (P,0.05; Fig. 4).
Representative immunohistochemistry photomicrographs showing MMP-2
and MMP-9 levels in the mouse aortas are shown in Fig. 5. Significantly higher
MMP-2 (41.6% vs. 10.6%; Fig.5A) and MMP-9 (58.8% vs. 18%; Fig. 5B) levels
were found in the aortas of mice exposed to Cd compared with unexposed
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controls (P,0.001). Interestingly, there was a marked decrease in MMP-2 and
MMP-9 levels (approaching normal values) in Cd-exposed mice treated with
THU (P,0.001; Fig. 5A, B). In addition, there was no significant difference in the
aortic wall composition and MMP-2 and MMP-9 levels in normal control mice
after supplementation with THU (data not shown).
THU Alleviates Cd-Induced Oxidative Stress
Table 2 shows the levels of O2
N-, oxidative stress markers and antioxidant GSH in
all experimental groups. Results showed that administration of THU did not
change the levels of oxidant and antioxidant in control mice when compared with
those receiving the vehicle alone. Cd exposure for 8 weeks induced a marked
production of O2
N- in the thoracic aorta and reduced blood GSH when compared
to those of normal controls (P,0.05; Table 2). THU at both doses significantly
reduced the rate of O2
N- production when compared to mice treated with Cd alone
(P,0.05; Table 2). Similarly, treatment with THU, especially at high dose, showed
an impressive recovery of blood GSH compared to Cd-treated controls (P,0.05;
Table 2). Further confirming increased oxidative stress associated with Cd-
induced hypertension, we found that mice treated with Cd showed higher MDA
levels in plasma and tissues, including heart, liver and kidney than the Cd-treated
controls (P,0.05; Table 2). In addition, increased protein carbonyl levels in
plasma and tissues were found in mice treated with Cd (P,0.05; Table 2). THU
dose-dependently reduced both MDA and protein carbonyl levels (P,0.05;
Table 2). It appears that the antioxidant activity of THU is well correlated with a
Table 2. Effect of THU on oxidative stress and redox status in all experimental groups.
Parameters Untreated control Control + THU (mg/kg) Cd control Cd + THU (mg/kg)
50 100 50 100
Aortic superoxide anion (Counts/mg dry wt./min) 126¡7 123¡5 121¡ 8 1060¡86* 436¡ 28*{ 233¡18*{
Blood GSH (mM) 810¡70 775¡85 806¡82 285¡24* 528¡32*{ 752¡80{
Urinary nitrate/nitrite (nmol/mg creatinine) 881¡87 819¡115 864¡153 1866¡218* 1463¡246*{ 1014¡111*{
Malondialdehyde
Plasma(mM) 14¡0.4 13¡0.5 12¡0.7 39¡2* 38¡ 1.3* 15¡1{
Heart (mmol/mg protein) 7¡ 0.7 6¡0.6 6.¡ 0.1 10¡0.1* 9¡0.5* 6¡0.6{
Liver (mmol/mg protein) 3¡0.8 3¡0.9 3¡0.3 7¡0.5* 5¡0.7*{ 3¡0.3{
Kidney (mmol/mg protein) 5¡0.7 6¡1.1 5.¡0.6 9¡0.3* 7¡0.2*{ 5¡ 1{
Protein carbonyl (nmol/mg protein)
Plasma 1.4¡0.1 1.5¡0.3 1.5¡0.7 4¡0.4* 2.4¡0.3*{ 1.2¡0.4{
Heart 14¡ 3 13¡5 14¡5 25¡3* 18¡01*{ 16¡ 0.2{
Liver 22¡5 25¡4 21¡3 31¡3* 25¡3*{ 21¡4{
Kidney 12¡3 13¡1 12¡3 18¡0.8* 13¡2{ 13¡3{
GSH, Glutathione. Data are expressed as mean¡ SEM., n5/group. n5 8–10/group, *P,0.05 compared with normal control group, {P,0.05 compared with
Cd control group.
doi:10.1371/journal.pone.0114908.t002
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decrease in blood pressure and improvement in the vascular responsiveness of Cd-
treated mice.
THU Reduces Cd Accumulations in Blood and Tissues
A marked increase in Cd content was found in blood and tissues, including heart,
aorta, liver and kidney of mice after an 8-week exposure (Fig. 6A, B, C).
Fig. 3. Effect of THU on the relative wall thickness (A), circumferential extension ratio (B), Ep (C), and Einc (D) of mice thoracic aortas in all
experimental groups. Results are expressed as mean ¡ SEM., n56–8/group. In animals not treated with Cd, THU has no effect on aortic elasticity of
normal control mice (data not shown). (A)*P,0.05 compared with normal control group at various pressures. {P,0.05 compared with Cd control group at
various pressures. (B)*P,0.05 compared with normal control group at pressures ranging from 160–200 mmHg; {P,0.05 compared with normal control
group at pressures ranging from 180–200 mmHg); {P,0.05 compared with Cd control group at pressures ranging from 160–200 mmHg. (C)*P,0.001
compared with normal control group at pressures ranging from 100–200 mmHg; {P,0.5 compared with normal control group at pressures ranging from
120–200 mmHg; {P,0.05 compared with Cd control group at pressures ranging from 120–200 mmHg. (D)*P,0.05 compared with all group (from 1.7);
{P,0.05 compared with normal control (from 1.9); {P,0.05 compared with Cd control group (from 1.7).
doi:10.1371/journal.pone.0114908.g003
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Fig. 4. Effect of THU on smooth muscle cell numbers and percent of area fraction of collagen and elastin content in the aortic media of mice with
or without Cd exposure. Panels A, B and C are representative photographs of aortic samples (6250) stained with H&E, picrosirius red and Miller’s elastic
stain, respectively. Results are expressed as mean ¡ SEM., n56–8/group. *P,0.05 compared with normal control group; {P,0.05 compared with Cd
control group.
doi:10.1371/journal.pone.0114908.g004
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Supplementation with THU in a dose-dependent manner significantly decreased
Cd accumulations in blood and the tissues as shown in Fig. 6.
To test that the mode of action of THU is not merely due to the interference of
gastrointestinal absorption, we have performed some supplementary experiments
by giving Cd and THU to mice directly via intravenous injection. Data obtained
from mice acutely exposed to Cd by intravenous injection showed a significant
increase in arterial blood pressure, and THU reduced systolic blood pressure with
a slight decrease in mean arterial pressure (S1 Figure). THU also reduced
oxidative stress by decreasing vascular superoxide production and the levels of
MDA in plasma and tissues. Interestingly, the amount of Cd in the blood of mice
receiving Cd directly via intravenous injection was also elevated and declined after
Fig. 5. Effect of THU on MMP-2 (A) and MMP-9 (B) localization assessed by immunohistochemistry in the aortas of all experimental groups. Panels
A and B are representative photographs of MMP-2 and MMP-9 expressions respectively (4006). Results are expressed as mean¡ SEM., n56–8/group.
*P,0.001 compared with normal control group; {P,0.001 compared with Cd control group.
doi:10.1371/journal.pone.0114908.g005
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THU treatment (S1 Figure). Data from both acute and sub-chronic exposures to
Cd suggest a potential chelating effect of THU.
Discussion
The major findings of this study are that Cd exposure induces hypertension,
vascular dysfunction and vascular stiffening by remodeling of the vascular
scleroproteins and increased oxidative stress. The consequences of Cd exposure
include blunted vascular responses to vasoactive substances, reduced arterial
compliance and decreased endothelial NO activity due to a reduction in NO
bioavailability. We have found that administration with THU led to a significant
reduction in the detrimental effect of Cd-induced hypertension and vascular
injury in mice. The plausible mechanisms might be related to the ability of THU
to restore the NO bioavailability in the vascular system, suppress MMP-induced
vascular remodeling, reduce oxidant formation and maintain antioxidant GSH. In
this study, increased arterial blood pressure in mice with Cd exposure,
corroborates previous reports that Cd is a risk factor for hypertension
[2, 7, 10, 33, 35, 41]. Cd perturbs vascular health and interferes with vascular
function [7, 17]. Previous studies suggest that Cd increases oxidative stress and
Fig. 6. Effect of THU on Cd accumulation in the blood and tissues of mice exposed to Cd. Results are expressed as mean¡ SEM., n56-8/group.
*P,0.05 compared with normal control group, {P,0.05 compared with Cd control group.
doi:10.1371/journal.pone.0114908.g006
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attacks endothelium and VSMCs in a variety of ways, thereby leading to vascular
damage and abnormal function [16–17, 42–43]. This study has confirmed that Cd
exposure induces hypertension which may both be the cause and the consequence
of functional and structural alterations in the aorta. We found that Cd induced
vascular dysfunction by attenuating the response of VSMC to vasoactive agents.
The blunted response of Phe-induced contraction reported here may be explained
by Cd provoking enhanced Ca2+- channel antagonism and thus, resulting in the
reduction of Phe contraction [44]. The suppression of the vascular response to
ACh after Cd exposure can be explained by decreasing endothelium-dependent
vaso-relaxation which is due to down-regulation of eNOS expression, as found in
this study, as well as an NO-dependent pathway dysfunction in the vascular
endothelium [15]. Moreover, the attenuation of vascular reactivity to SNP
observed here might be due to a long-term damage of VSMCs caused by Cd
intoxication.
Apart from BP elevation, we also found that the aortic wall of Cd exposed mice
becomes thicker and stiffer than normal, and that these alterations are associated
with changes in vessel composition. Therefore, changes in mechanical forces
during Cd exposure might lead to adaptive restructuring of the vessel wall.
Reorganization of the extracellular matrix through protein synthesis and
degradation is a key characteristic of hypertensive vascular remodeling [45–46].
Recent studies have shown evidence of MMP activation via NADPH oxidase-
derived ROS leading to increased mechanical stretch [47–48]. In this study,
enhanced expression of arterial MMP-2 and MMP-9 has been observed in mice
on exposure to Cd, and these findings are associated with increased BP and
modifications of vascular wall composition. Our results are in agreement with
previous studies showing that Cd increased MMP-9 and MMP-2 levels which
induced inflammation and proliferation [49–50]. Therefore, we suggest that
increased MMP activation and reduced arterial compliance may very well
contribute to hypertensive remodeling during Cd exposure.
The role of nutritional compounds in the prevention and treatment of
hypertension has attracted considerable interest over the last decade. Among
these, THU, a strong antioxidant, has been shown to exert antihypertensive
activity and reduce aortic stiffening [30].
It is well established that NO produced from endothelial cells possesses diverse
bioactivity, including smooth muscle relaxation and vasodilation, antioxidant
properties, platelet disaggregation, anti-inflammatory and anti-thrombogenic
activity, and the inhibition of cell growth, proliferation and migration [51].
Reduction in NO bioavailability may be caused by decreased eNOS expression
[52], a lack of substrate or cofactors for eNOS [53], alteration of cellular signaling
such that eNOS is not appropriately activated and finally, accelerated NO
degradation by ROS. In general, a major source of NO in the vascular system is
from eNOS. The present results show a significant decrease of aortic eNOS
expression in the aortas of Cd exposed mice. This is in agreement with previous
studies that found decreased eNOS levels in the blood vessels of Cd-induced
hypertensive rats [15]. Reduced eNOS expression in this study may be due to the
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downregulation of eNOS gene expression. Cd-induced vascular dysfunction
would, in addition to damaging the integrity of the vascular endothelium,
promote vascular inflammation [5]. A variety of proinflammatory mediators such
as TNF-a may activate iNOS and generate high concentrations of NO-mediated
disorders [54]. Overproduction of NO via the iNOS pathway was found in this
study. We suggest that iNOS-generated NO suppresses the expression of eNOS,
suppresses guanylate cyclase activity and thereby induces a state of endothelial and
smooth muscle dysfunction [55]. Altogether, our results show that THU can
restore vascular function and structure associated with the eNOS/iNOS regulatory
pathway in Cd-induced hypertensive mice.
Cd causes oxidative stress by inducing the generation of ROS and RNS,
reducing the antioxidant defense systems of cells by depleting GSH, inhibiting SH-
dependent enzymes, interfering with some essential metals needed for antioxidant
enzyme activities, and/or increasing susceptibility of cells to oxidative attack by
altering the membrane integrity and fatty acid composition [56–57]. Cd exposure
is associated with increased production of ROS, especially O2
N-[3]. Moreover,
increased O2
N- production can induce iNOS expression through NF-kB activity
which in turn may augment NO production [58]. As shown in our results, Cd
exposure causes an increase in O2
N- production and iNOS expression in the
thoracic aorta. Induction of iNOS produces excessive amounts of NO, which
reacts with O2
N- to form the even more potent oxidant peroxynitrite (ONOO-).
Both O2
N- and ONOO- have been implicated in tissue injury and dysfunction of
organs, including blood vessels, heart, liver, and kidney. Treatment with THU
markedly decreased O2
N- production in the aorta and decreased the ratio of
urinary nitrate/nitrite in a dose-dependent manner. Decreased iNOS expression
was related to a decline in O2
N- and nitrate/nitrite levels, thereby, reducing ONOO-
formation and causing increased NO bioavailability.
It is known that heavy metals, such as Cd, produce many of their adverse effects
by the formation of free radicals, resulting in DNA damage, lipid peroxidation,
and depletion of protein sulfhydryls (e.g. GSH) [3, 59]. Our results have shown
significant suppression of oxidant formation by THU as indicated by inhibition of
the high levels of O2
N-, MDA and protein carbonyl, whereas endogenous
antioxidant GSH was increased by THU administration in Cd exposed mice.
These results suggest that vascular protection in the THU-treated group is
probably due to suppression of oxidative stress. Histological examination further
confirmed the protective effect of THU on Cd-induced oxidative stress and
vascular toxicity. Previous studies have shown the antihyperlipidemic and
cardiovascular protective effects of THU [24, 28, 31]. Pari and Amali have
reported that THU confers significant protection against chloroquine induced
toxicity by its ability to inhibit lipid peroxidation through the free radical
scavenging activity, which enhanced the antioxidant defense system.[26] As a
possible molecular mechanism for the antioxidant action of THU, it has been
suggested that the beta-diketone moiety of THU exhibits antioxidant activity by
cleavage of the C-C bond at the active methylene carbon between two carbonyls in
the beta-diketone moiety [23, 60].
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Cd accumulates mainly in the liver, kidneys, heart and aorta which cause tissue
damage in these organs [14, 61-62]. We found that the Cd content in these organs
and the blood was decreased in Cd exposed mice with THU co-administration.
The large reduction in Cd concentration in the blood after THU treatment
suggests that THU, like curcumin, may be able to chelate Cd by forming a metal-
ligand complex, thereby reducing the Cd load in the body [63]. A potential
chelating effect of THU at the tested dose is supported by the improvement of
hemodynamic and vascular responses to a great extent; in particular a low dose of
THU improved those variables. Moreover, data from supplementary experiments
revealed the chelating and antioxidant properties of THU in mice receiving Cd
directly via intravenous injection. Apart from being a chelating and antioxidant
agent, THU might also have the ability to interfere with the gastrointestinal
absorption of Cd, thereby, causing a reduction in Cd content in the blood and
tissues. However, the specific mechanism is not clear and deserves further
investigation.
In conclusion, the results obtained in this study provide the first experimental
evidence that THU protects against hypertension, increased arterial stiffness,
vascular remodeling and oxidative stress during Cd intoxication. The data suggest
that THU as a chelating and antioxidant agent plays an important role in lessening
the adverse effects of exposure to Cd. Although the results of this study revealed
the protective effect of THU during Cd exposure, the therapeutic effect of THU
after Cd exposure is another important aspect and merits further detailed
investigation. Collectively, these findings suggest a beneficial effect in using
antioxidant THU as a dietary supplement following heavy metal exposure, or as a
complimentary chelating agent to increase the efficacy of a known chelator in
order to minimize the metal’s toxicity.
Supporting Information
S1 Figure. Effect of THU on mice acutely exposed to Cd by intravenous
injection. Cd treated group, mice received CdCl2 (100 mg/ml) in saline by
intravenous injection via the tail vein, once daily for 3 days; the injection volume
was 200 ml/mouse. Cd+THU treated group, mice were intravenously admini-
strated with Cd once daily, and THU (372 mg/ml) in 0.5% DMSO, for 2 times a
day (30 min after Cd injection and in the evening) for 3 days. Control group, mice
were injected with saline and 0.5% DMSO, 2 times a day for 3 days. Results are
expressed as mean¡ SEM., n53/group. *P,0.05 compared with normal control
group, #P,0.05 compared with Cd control group.
doi:10.1371/journal.pone.0114908.s001 (TIF)
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